TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
CRSP

Crispr Therapeutics AG

Healthcare · Biotechnology

54.20$ -2.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Crispr Therapeutics AG (CRSP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,651 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CRSP
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
279 345 322 305 282 271 374 353 519 489 498 494 721 1,067 1,007 1,047 1,485 1,828 1,958 2,900 2,822 2,752 2,606 2,463 2,353 2,243 2,244 2,197 2,087 2,230 2,439 2,340 2,256 2,242 2,166 2,030 2,245 2,265 2,726 2,651
232 320 296 281 259 248 351 331 497 466 450 438 664 988 929 966 1,391 1,717 1,832 2,621 2,519 2,418 2,261 2,107 1,933 1,853 1,908 1,860 1,761 1,908 2,120 2,010 1,944 1,937 1,868 1,734 1,929 1,976 2,448 2,372
229 316 289 272 254 240 342 320 487 457 438 428 630 944 890 945 1,041 1,169 1,126 1,647 1,012 923 684 497 494 212 344 445 528 389 707 484 226 298 235 197 290 355 423 291
229 316 289 272 254 240 342 320 487 457 438 428 630 944 890 945 1,366 1,690 1,806 2,589 2,477 2,379 2,221 2,065 1,896 1,815 1,883 1,768 1,740 1,694 2,108 2,002 1,936 1,904 1,855 1,725 1,916 1,976 2,442 2,364
2.1 3.2 5.7 6.8 3.2 2.6 1.3 0.9 0.6 0.1 0.3 0.3 0.0 0.1 25 0.0 0.1 11 0.2 0.2 0.2 0.3 0.1 0.1 0.0 11 – 70 – 200 0.0 0.0 0.0 25 0.0 0.0 0.0 0.0 – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – 0.0 – – – – 0.0 – – – – – 0.0 -11 – 0.0 – – – – – – – – – – – –
3.9 21 22 20 20 19 19 18 18 19 19 51 52 73 72 74 38 42 52 255 106 138 157 332 166 164 162 319 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 – – – – – – – – –
341 112 107 107 103 84 84 88 102 97 118 127 129 127 121 136 142 164 152 296 309 352 361 373 399 368 389 381 359 347 355 359 316 310 337 319 329 343 911 904
78 22 17 16 12 15 14 18 32 28 28 31 80 57 55 75 84 94 83 100 96 120 114 120 151 121 147 133 111 109 119 128 90 88 119 104 119 149 136 133
12 60 65 66 70 44 46 44 31 35 4.9 4.9 4.8 8.5 9.0 9.9 11 11 12 16 13 12 11 8.3 11 16 16 15 15 16 16 16 17 17 18 18 18 19 19 19
1.9 4.6 3.9 2.6 2.1 1.6 2.5 4.5 5.2 5.1 7.1 7.1 3.4 5.9 11 13 19 9.1 13 10 10 15 27 25 32 27 45 28 26 38 16 9.5 16 15 13 9.8 12 11 14 11
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 32 – – – – – – – – – – – – – – – – – – – – – – – – – – – 585 586
-62 233 215 198 179 188 290 265 417 392 380 368 592 939 886 911 1,343 1,664 1,805 2,604 2,513 2,399 2,245 2,091 1,954 1,875 1,855 1,816 1,728 1,883 2,084 1,981 1,940 1,932 1,829 1,711 1,916 1,922 1,815 1,747
-74 -57 -79 -101 -126 -125 -155 -193 -244 -292 -340 -394 -255 -225 -294 -374 -467 -574 -687 72 -55 -196 -375 -561 -736 -846 -899 -977 -1,089 -1,000 -1,116 -1,243 -1,329 -1,366 -1,502 -1,710 -1,817 -1,948 -2,070 -2,162
40 40 40 40 40 46 46 47 47 52 52 53 58 60 61 61 70 70 75 80 76 77 77 78 78 78 79 79 79 81 82 85 85 85 86 87 91 90 96 97

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?